Product Information
GEMFIBROZIL 600 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1034 per EA under NDC 69097082103. Its NADAC has been published 516 times since Aug 10, 2016.
Strength
600 mg/1
Manufacturer
Cipla USA Inc.NDC
69097082103
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GEMFIBROZILApproval Type
Generic (ANDA)
FDA Application
ANDA077836On Market Since
10/13/2016
Pharmacological Classes
Price Statistics
The NADAC for GEMFIBROZIL 600 MG TABLET has been published 516 times since Aug 10, 2016, and over the history we have for it it has risen 10.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1034 per EA |
|---|---|
| All-time high | $0.1158 (Sep 11, 2019) |
| All-time low | $0.0831 (Dec 20, 2017) |
| 52-week high | $0.1075 |
| 52-week low | $0.1005 |
| Median price | $0.1037 |
| Average price | $0.1015 |
| Largest weekly change | -18.6% (Apr 17, 2024) |
| Weeks tracked | 516 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GEMFIBROZIL 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GEMFIBROZIL 600 MG TABLET, manufactured by Cipla USA Inc., is $0.1034 per EA (NDC 69097082103), effective Jun 24, 2026.
How has the price of GEMFIBROZIL 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GEMFIBROZIL 600 MG TABLET has risen 10.4%. It has been tracked across 516 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for GEMFIBROZIL 600 MG TABLET?
Since Aug 10, 2016, the NADAC for GEMFIBROZIL 600 MG TABLET has ranged from a low of $0.0831 (Dec 20, 2017) to a high of $0.1158 (Sep 11, 2019), with a median of $0.1037 per EA.
Are there cheaper alternatives to GEMFIBROZIL 600 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GEMFIBROZIL 600 MG TABLET, is $0.0891 per EA — about 14% below GEMFIBROZIL 600 MG TABLET.
Who manufactures GEMFIBROZIL 600 MG TABLET?
GEMFIBROZIL 600 MG TABLET (NDC 69097082103) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification